Talks with partner are probably in final stages. One of the conditions was that they get rid of that Cuba flag off their web site and dispose of NIMO! I see 2 by end of the month. If partnership is for U.S. and Europe rights then 4+! Hopefully we have a deal by year end but I say no later than end of 1st qrt 2013. They need to get the trial going ASAP. It's a steal at 1.65. As partnership news leaks look for record volume!
collaboration could mean a discovery collaboration where YMI's library of JAK inhibitors is mined by the other company to identify a next gen JAK 1 or 2 inhibitor for RA or other indications, but he might have also meant a co-promote in which cyt387 is promoted by YMI in one jurisdiction and by the other company in another jurisdiction. As for handoff, that likely means the other company takes over ph III development - it doesn't necessarily mean a buyout but it could if, as i suggested in another post, Glover is looking at putting a bow on YMI and auctioning the company to the highest bidder (which some biotechs have done)